MassMutual backs Oncoshot

Singapore-based Oncoshot announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors.

Founded in 2018, Oncoshot helps patients, caregivers and oncologists find cancer clinical trials anywhere in the world. Its federated data system houses critical and sensitive patient data within hospital premises, protecting the data as it is never transferred out of original storage. The analyses and insights generation happens within the hospital system, conferring control, access, and protection fully to hospital administrators.

“There is great value in creating a health insights exchange platform that can bring different clinical trial stakeholders together. The Oncoshot solution addresses the frustrations faced by both industry and clinical players in terms of patient recruitment. The fact that this company has gained such traction with multiple hospitals highlights this need.” – Mr Anvesh Ramineni, managing director, MMV.